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Abstract: Chiral oxacyclic frameworks are prevalent in many 
natural products and bioactive compounds.  In addition, a 
number of them are important synthetic intermediates.  Thus, 
the synthesis of such structures is a significant goal in the field 
of organic chemistry.  However, the development of catalytic 
asymmetric cycloetherification for the straightforward 
synthesis of these compounds remains a challenge.  In this 
study, we propose the use of aminothiourea catalysis as an 
effective way to accomplish such a challenge.  The asymmetric 
synthesis of chiral oxygen heterocycles, including 
tetrahydrofurans, tetrahydropyrans, and 1,3-dioxolanes, is 
demonstrated herein using intramolecular oxy-Michael addition 
mediated by bifunctional aminothiourea catalysts. 
Key words: oxycyclization, cycloetherification, hydrogen 
bonding, bifunctional aminothiourea catalyst, oxy-Michael 
addition 
Cyclization from unsaturated substrates that bear a 
pendant nucleophilic oxygen atom is a straightforward 
way to synthesize chiral oxacyclic compounds.  
However, asymmetric oxycyclization reactions are 
highly challenging because of the difficulty in 
installing a suitable chiral environment during the 
rapid intramolecular process.  On the other hand, 
several asymmetric azacyclizations have successfully 
been developed, including enantioselective 
intramolecular aza-Michael additions using a proline-
derived catalyst
1
 or a chiral phase-transfer-catalyst.
2
  
The enantioselection of these azacyclizations was 
largely controlled by the effects of the substituents on 
the nucleophilic nitrogen atom through steric 
repulsion or π-interactions.  Meanwhile, because such 
a substituent is lacking in the oxycyclization 
substrates, those strategies can only be applied to 
starting materials that bear an appropriate substituent 
in the vicinity of the alcohol.
3,4
  Therefore, a novel 
strategy is required to obtain an efficient asymmetric 
oxycyclization reaction.  In this context, hydrogen 
bonding is an interaction with the potential to be able 
to control the behavior of a pendant OH group 
(Scheme 1).  Thus, the use of organocatalysts that 
utilize hydrogen bonding
5
 is a promising approach to 
realizing enantioselective oxycyclization.  Moreover, 
multipoint recognition by an asymmetric catalyst 
would be favorable for the achievement of effective 
transfer of the chiral information during the 
cyclization process (Scheme 1). 
 
Scheme 1 Strategies for asymmetric aza- and oxycyclizations. 
(PG: protecting group) 
Evidence for the validity of this concept can be found 
in some recent reports on catalytic asymmetric 
halolactonizations using bifunctional organocatalysts.  
These allow multipoint interactions in the reaction 
transition states, one of which is hydrogen bonding 
with the pendant carboxyl group.
6
  In addition, a 
number of other highly enantioselective 
oxycyclizations using organocatalysts have been 
developed, where hydrogen bonding is thought to 
have played a role in controlling the chirality.
7–10
 
However, whereas an increasing number of methods 
for asymmetric cyclolactonizations have recently been 
reported,
6
 examples of cycloetherifications are still 
limited.
3,7,9,10
  In particular, catalytic enantioselective 
cycloetherifications are extremely challenging 
because of the higher nucleophilicity of hydroxyl 
groups compared to carboxyl groups.  In fact, several 
of the previously reported cycloetherifications 
demonstrated only moderate enantioselectivity, 
resulting from background racemic reactions that 
occurred, even at low temperatures.  They therefore 
required a stoichiometric or extremely high loading of 
chiral mediators in order to achieve acceptable 
selectivity.
11
  To overcome such drawbacks, we 
developed an intramolecular oxy-Michael addition 
reaction
12
 by employing bifunctional aminothiourea 
catalysts
13
 that utilize hydrogen bonding at both 
catalytic sites.  It was hypothesized that the mild 
character of hydrogen bonding would facilitate 
concerted catalysis through multipoint recognition, 
even with highly reactive substrates, for 
cycloetherification (Scheme 2).
7a,b 
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Scheme 2 Asymmetric cycloetherification via intramolecular oxy-
Michael addition reaction mediated by bifunctional organocatalyst. 
Herein, we describe a highly enantioselective catalytic 
cycloetherification for the synthesis of 2-substituted 
tetrahydrofurans (Table 1) and tetrahydropyrans 
(Table 2).
14
  An intramolecular oxy-Michael addition 
reaction from ε- or ζ-hydroxy-α,β-unsaturated ketones 
could be performed in a highly enantioselective 
fashion by using cinchona-alkaloid-thiourea-based 
bifunctional organocatalyst 3a (Figure 1).  Screening 
of the catalysts shown in Figure 1 further 
demonstrated that 3c is an efficient catalyst for 
obtaining the opposite enantiomer ent-2a in excellent 
yield with high enantioselectivity (Table 1, entry 2).  
Moreover, the catalytic loading could be decreased to 
as low as 1 mol % in the THF synthesis, while still 
giving excellent enantioselectivity (Table 1, entry 3).  
This catalytic process is a highly practical 
cycloetherification method that provides excellent 
enantioselectivities, even with low catalyst loadings at 
ambient temperature.  Although the reactions were 
slower, a similar reaction condition also led to the 
highly enantioselective synthesis of 2-substituted 
tetrahydropyrans (Table 2). 
Table 1. Asymmetric Synthesis of 2-Substituted Tetrahydrofurans 











1 Ph 2a 99 95 
2
d 
Ph ent-2a 99 –96 
3
e 
Ph 2a 95 96 
4
 
4-CH3OC6H4 2b 99 94 
5
f 
4-CF3C6H4 2c 93 85 
6 2-naphthyl 2d 98 91 
7 4-CH3C6H4 2e 99 93 
8 4-BrC6H4 2f 99 92 
9
g
 C6H5(CH2)2 2g 97 90 
a
 Reactions were run using 1 (0.25 mmol) and 3a (0.0075 mmol) in 
CPME (0.5 mL). 
b
 CPME = cyclopentyl methyl ether. 
c
 Isolated yields. 
d
 Reaction was run using 3c instead of 3a. 
e
 Reaction was run using 1 mol % 3a (0.0025 mmol). 
f
 Reaction was run on a 0.125 mmol scale. 
g
 Reaction was run for 120 h. 
 
 
Figure 1 Cinchona-alkaloid-derived aminothiourea catalysts. 
 
Table 2. Asymmetric Synthesis of 2-Substituted Tetrahydropyrans 











1 Ph 5a 90 91 
2
 
4-CH3OC6H4 5b 56 94 
3
d 
4-CF3C6H4 5c 95 85 
4 2-naphthyl 5d 80 94 
5 4-CH3C6H4 5e 76 94 
6 4-BrC6H4 5f 99 94 
7
e 
C6H5(CH2)2 5g 58 95 
a
 Reactions were run using 1 (0.15 mmol) and 3a (0.0075 mmol) in 
CPME (0.3 mL). 
b
 CPME = cyclopentyl methyl ether. 
c
 Isolated yields. 
d
 Reaction was run on a 0.1 mmol scale. 
e
 Reaction was run for 120 h. 
 
The obtained THF product 2b could be further 
transformed into the corresponding ester 6 by means 
of Baeyer–Villiger oxidation with m-CPBA in the 
presence of TFA in 92% yield without any loss of 
optical purity (Scheme 3).  Subsequent reduction of 6 
with lithium aluminum hydride afforded (R)-2-
(tetrahydrofuran-2-yl)ethanol (7), which is a valuable 




Scheme 3 Transformation of 2b. 
These results subsequently motivated us to exploit this 
efficient oxycyclization protocol for the development 
of a catalytic formal [3+2] cycloaddition reaction 
starting from γ-hydroxy-α,β-unsaturated carbonyls
16
 
with aldehydes or ketones (Scheme 4).  This method 
led to the successful divergent synthesis of chiral 1,3-
dioxolanes.
17
  In this reaction, the hemiacetal 
intermediate generated in situ was the substrate for 
the cycloetherification mediated by chiral 
aminothiourea.
18,19 
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Scheme 4 Chiral 1,3-dioxolane synthesis via asymmetric 
cycloetherification using a bifunctional aminothiourea catalyst. 
Employing the conditions described in Table 3, 
various 1,3-dioxolanes were stereoselectively obtained 
by the formal cycloaddition reaction using 3a as a 
catalyst.
20
  In addition, catalyst screening identified 3c 
as an efficient catalyst for obtaining the opposite 
enantiomer ent-10aa in good yield with high 
enantioselectivity (Table 3, entry 2). 
Table 3. Asymmetric Synthesis of 1,3-Dioxolanes by 



















1 Ph, Cy, H 10aa 95 3.0:1 96 
2
f 
Ph, Cy, H ent-10aa 91 4.0:1 –93 
3
g 
4-CH3OC6H4, Cy, H 10ba 93 3.4:1 96 
4 4-CF3C6H4, Cy, H 10ca 83 2.5:1 95 
5 4-BrC6H4, Cy, H 10da 88 4.7:1 96 
6 2-CH3C6H4, Cy, H 10ea 71 3.3:1 91 
7 1-naphthyl, Cy, H 10fa 82 2.9:1 90 
8 2-thienyl, Cy, H 10ga 84 3.3:1 98 
9
h 
C6H5(CH2)2, Cy, H 10ha 82 3.3:1 96 
10 Ph, Et, H 10ab 94 3.0:1 94 
11 Ph, i-Pr, H 10ac 92 2.7:1 93 
12
i 
Ph, t-Bu, H 10ad 84 2.6:1 94 
13 Ph, CF3, Ph 10ae 99 1.2:1 70 
a
 Reactions were run using 8 (0.25 mmol), 9 (0.3 mmol), and 3a 
(0.025 mmol) in CPME (0.5 mL). 
b
 CPME = cyclopentyl methyl ether. 
c
 Isolated yields. 
d




 Values are for the major diastereomers of 10.  See ref 20 for 
minor diastereomers. 
f
 Reaction was run using 3c instead of 3a. 
g
 Reaction was run for 48 h. 
h
 Reaction was run for 96 h. 
i
 Reaction was run for 120 h. 
 
The utility of the products as synthetic intermediates 
was demonstrated by performing the transformation of 
10aa.  Reduction with lithium aluminum hydride in 
the presence of lithium iodide afforded the 
corresponding alcohol 11 with high 
diastereoselectivity, and subsequent de-acetalization 
gave optically active triol 12 (Scheme 5).  In addition, 
treatment of 10aa with allyltrimethylsilane in the 
presence of titanium tetrachloride led to allylative ring 
cleavage to provide 13 in a regio- and 
diastereoselective fashion while maintaining the 
optical purity (Scheme 6).
 
 
Scheme 5 Synthesis of chiral triol 12. 
 
Scheme 6 Stereospecific ring cleavage of 10aa. 
To gain further insight into the enantio-determining 
step, formal [3+2] cycloaddition reactions were 
investigated using formaldehyde (9f) and acetone (9g) 
with 8a (Scheme 7).  It was found that products 10af 
and 10ag were obtained enantioselectively, regardless 
of the achirality of the forming acetal carbon.  These 
results strongly suggest that the intramolecular oxy-
Michael addition from the hemiacetal intermediates 
proceeded with high enantioselectivity according to 
our original hypothesis.  This is also in agreement 
with the consistent absolute configuration (the same 
(S)-configuration) at the β-position of the carbonyl 
group in both diastereomers of 10da (Scheme 8).  
 
Scheme 7 Formal [3+2] cycloaddition with formaldehyde (9f) and 
acetone (9g). 
 
Scheme 8 The absolute configurations of 10da, as determined by 
X-ray analysis for both diastereomers.
21 
Considering these stereochemical outcomes, although 
the diastereoselectivity was only moderate, these 
reactions can be recognized as a way to achieve highly 
enantioselective oxygen atom introduction at the β-
position of the carbonyl group.  This cyclization 
protocol was therefore applied to reactions using 
carboxylic acid derivatives as substrates.  There have 
been very few demonstrations of asymmetric oxy-
Michael additions to high oxidation state substrates, 
such as α,β-unsaturated carboxylic acid derivatives,
22
 
despite their great synthetic importance.
23
 
By employing studies involving the optimization of 
substrates and reaction conditions, 2,6-
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dimethylbenzenethiol ester 14 was identified as the 
best substrate, and pivalaldehyde (9d) proved to be a 
good counterpart.  The reaction between these 
components, using 3a as a catalyst, gave a 
diastereomer mixture of the desired products (15 and 
15′) in high yield, with excellent enantioselectivity for 
both diastereomers (Scheme 9).
24
  Stereochemical 
analysis of the products revealed that these 
diastereomers had the same (S)-configuration at the β-
position of the carbonyl group as was expected.
25
 
The easily removable acetal functionality enables this 
oxy-Michael addition method to be useful as an 
enantioselective formal hydration.
26
  In order to 
demonstrate this, the obtained products were further 
extended to the asymmetric syntheses of some β-
hydroxy carboxyl compounds (Scheme 10).  
Treatment of the diastereomer mixture of 15 and 15′ 
with titanium tetrachloride led to the generation of 
free β,γ-dihydroxy compound 16 with high optical 
purity, while keeping the thioester group intact.  
Alternatively, treatment of the diastereomer mixture 
with p-toluenesulfonic acid in an aqueous medium 
gave β-hydroxy-γ-butyrolactone 17, a versatile chiral 
synthetic intermediate,
27
 which could be transformed 
into (L)-carnitine (18), an important bioactive agent, 
using a previously reported procedure.
28 
 




Scheme 10 Syntheses of chiral β-hydroxy carboxyl compounds.
 
Taking advantage of the thioester functionality, we 
also carried out functional group transformations of 
15, and it was found that the chiral acetal moiety was 
unchanged after the transformations (Scheme 11).  
Reduction of 15 with lithium aluminium hydride 
afforded the corresponding primary alcohol 19 
quantitatively, without any erosion of optical purity.  
In addition, Liebeskind–Srogl cross coupling enabled 
the replacement of the arylthio group of 15 to give 
ketone 10ad,
29
 indicating that these thioester products 
can be easily transformed into a wide variety of chiral 
compounds. 
 
Scheme 11 Transformations of the thioester group of 15.
 
In summary, we have demonstrated asymmetric 
intramolecular oxy-Michael addition reactions using 
cinchona-alkaloid-thiourea-based bifunctional 
organocatalysts.  The developed methods afforded 
several important oxacyclic compounds, including 
tetrahydrofurans, tetrahydropyrans, and 1,3-
dioxolanes.  A number of the resulting products were 
demonstrated to be useful synthetic intermediates that 
could be further transformed into valuable bioactive 
compounds.  This study indicates that the approach 
based on the use of hydrogen bonding is an effective 
way to achieve enantioselective cycloetherification.  
Further studies on the application of this methodology 
to the synthesis of other chiral oxygen heterocycles 
are currently underway in our laboratory and will be 





C Nuclear magnetic resonance spectra were 
taken on a Varian UNITY INOVA 500 (
1
H, 500 MHz; 
13
C, 125.7 MHz) spectrometer using tetramethylsilane 
as an internal standard for 
1
H NMR (δ = 0 ppm) and 
CDCl3 as an internal standard for 
13
C NMR (δ = 77.0 
ppm).  When a 
13
C NMR spectrum was measured 
using C6D6 as a solvent, C6D6 was used as an internal 
standard (δ = 128.06 ppm).  
1
H NMR data are 
reported as follows: chemical shift, multiplicity (s = 
singlet, d = doublet, t = triplet, q = quartet, quint = 
quintet, sext = sextet, sept = septet, br = broad, m = 
multiplet), coupling constants (Hz), integration.  
19
F 
NMR spectra were measured on a Varian Mercury 200 
(
19
F, 188 MHz) spectrometer with hexafluorobenzene 
as an internal standard (δ = 0 ppm).  GC-MS analyses 
and High-resolution mass spectra were obtained with 
5 SYNTHESIS: SPECIAL TOPIC (INVITED ARTICLE)  
Template for SYNLETT and SYNTHESIS © Thieme  Stuttgart · New York 2014-09-18 page 5 of 10 
a JEOL JMS-700 spectrometer by electron ionization 
at 70 eV.  High performance liquid chromatography 
(HPLC) was performed with a SHIMADZU 
Prominence.  Infrared (IR) spectra were determined 
on a SHIMADZU IR Affinity-1 spectrometer.  
Melting points were determined using a YANAKO 
MP-500D.  Optical rotations were measured on a 
HORIBA SEPA-200.  X-ray data were taken on a 
Bruker Smart APEX X-Ray diffractometer equipped 
with a large area CCD detector.  The structures were 
solved with the program system SHELXS-97 and 
refined with SHELXL-97 package from Bruker.  TLC 
analyses were performed by means of Merck 
Kieselgel 60 F254 (0.25 mm) Plates.  Visualization was 
accomplished with UV light (254 nm) and/or such as 
an aqueous alkaline KMnO4 solution followed by 
heating. 
Flash column chromatography was carried out using 
Kanto Chemical silica gel (spherical, 40–50 μm).  
Unless otherwise noted, commercially available 
reagents were used without purification. 
 
General procedure for preparation of bifunctional 
aminothiourea catalysts 3 
Bifunctional organocatalysts 3 were prepared by the 
literature procedure.
13c
  A cinchona alkaloid (5 mmol) 
and triphenylphosphine (1.6 g, 6 mmol) were 
dissolved in THF (25 mL), and the solution was 
cooled to 0 °C.  Diethyl azodicarboxylate (1.0 g, 6 
mmol) was subsequently added.  To the resulting 
solution was added dropwise the solution of diphenyl 
phosphoryl azide (1.3 mL, 6 mmol) in THF (10 mL) 
at 0 °C.  The mixture was allowed to warm to ambient 
temperature.  After being stirred for 24 h, it was 
heated to 50 °C and stirred for 10 h.  
Triphenylphosphine (1.7 g, 6.5 mmol) was added 
again, and the mixture was stirred at 50 °C for 
additional 15 h.  After the solution was cooled to 
ambient temperature, H2O (0.5 mL) was added, and 
the solution was stirred for 24 h.  The solvents were 
removed in vacuo, and the residue was dissolved in 
CH2Cl2/10% aqueous hydrochloric acid (25 mL/25 
mL).  The aqueous phase was separated and washed 
with CH2Cl2 (25 mL  4).  It was subsequently made 
alkaline with aqueous ammonia, and the aqueous 
phase was extracted with CH2Cl2 (25 mL  4).  The 
combined organic layers were dried over Na2SO4, and 
concentrated in vacuo.  Purification by flash silica gel 
column chromatography using EtOAc/CH3OH (v/v = 
9/1) then CHCl3/CH3OH (v/v = 8/2) as an eluent gave 
the corresponding 9-amino(9-deoxy)cinchona 
alkaloids.  Next, to the solution of the obtained 9-
amino(9-deoxy)cinchona alkaloid in THF (6 mL) was 
slowly added a solution of 3,5-
bis(trifluoromethyl)phenyl isothiocyanate (1 equiv) in 
THF (4 mL) at ambient temperature.  The mixture was 
stirred overnight, and the solvents were removed in 
vacuo.  Purification by flash silica gel column 
chromatography using EtOAc/CH3OH (v/v = 95/5–
97.5/2.5) or EtOAc as an eluent gave the 
corresponding bifunctional organocatalyst 3. 
 
3a. White solid; 41% yield (1.2 g) (for 2steps from 
quinidine).  [α]D
23
122.6 (c 1.33, CH2Cl2).  
1
H NMR 
(CDCl3) δ 8.65 (br s, 1H), 8.02 (d, J = 9.0 Hz, 1H), 
7.86 (s, 2H), 7.67 (s, 1H), 7.59 (br s, 1H), 7.40 (d, J = 
9.0 Hz, 1H), 7.23 (br s, 1H), 5.86 (br s, 2H), 5.19 (br s, 
1H), 5.15 (d, J = 9.5 Hz, 1H), 3.97 (s, 3H), 3.22 (br s, 
1H), 3.10 (br s, 1H), 3.03 (m, 2H), 2.94 (m, 1H), 2.38 
(m, 1H), 1.70 (s, 1H), 1.61 (m, 2H), 1.27 (br s, 1H), 
1.02 (m, 1H).  
13
C NMR (CDCl3) δ 181.0, 158.1, 
147.3, 144.7, 144.5, 140.1, 139.6, 132.5 (q, J = 33.6 
Hz), 131.6, 128.0, 123.5, 122.9 (q, J = 273.0 Hz), 
122.3, 118.7, 115.3, 101.7, 61.4, 55.6, 48.5, 47.1, 38.7, 
27.1, 26.1, 25.0.  Mp. 125.0–125.2 °C.  IR (KBr): 
3221, 2944, 2361, 1735, 1623, 1511, 1475, 1384, 
1278, 1177, 1134, 1034, 959, 916, 884, 850, 826, 682 
cm
–1
.  HRMS Calcd for C29H29F6N4OS: [M+H]
+
, 
595.1966. Found: m/z 595.1961. 
 
3b. White solid; 36% yield (1.0 g) (for 2steps from 
cinchonine).  [α]D
23
163.3 (c 1.23, CH2Cl2).  
1
H NMR 
(CDCl3) δ 8.83 (br s, 1H), 8.28 (br s, 1H), 8.15 (d, J = 
8.5 Hz, 1H), 7.85 (br s, 2H), 7.56 (dd, J = 7.5, 7.5 Hz, 
1H), 7.68 (s, 1H), 7.64 (dd, J = 7.5, 7.5 Hz, 1H), 7.29 
(br s, 1H), 5.81 (br s, 2H), 5.14 (m, 2H), 3.21 (br s, 
1H), 3.00 (m, 3H), 2.92 (br s, 1H), 2.36 (m, 1H), 1.66 
(s, 1H), 1.59 (m, 2H), 1.22 (br s, 1H), 0.95 (m, 1H).  
13
C NMR (CDCl3) δ 181.3, 150.0, 148.6, 145.8, 140.2, 
139.3, 132.5 (q, J = 33.6 Hz), 130.5, 129.5, 127.1, 
126.7, 123.4, 122.9 (q, J = 273.1 Hz), 122.8, 119.0, 
118.7, 115.5, 61.8, 55.7, 48.5, 47.0, 38.9, 27.3, 26.0, 
24.9.  Mp. 189.9–190.3 °C.  IR (KBr): 3428, 3246, 
2944, 2360, 1622, 1588, 1512, 1474, 1386, 1281, 
1183, 1126, 960, 882, 848, 752, 682 cm
–1
.  HRMS 
Calcd for C28H27F6N4S: [M+H]
+
, 565.1861. Found: 
m/z 565.1855. 
 
3c. White solid; 27% yield (0.80 g) (for 2steps from 
quinine).  [α]D
23
 –99.0 (c 1.24, CH2Cl2).  
1
H NMR 
(CDCl3) δ 8.60 (br s, 1H), 8.00 (d, J = 8.5 Hz, 1H), 
7.82 (br s, 2H), 7.68 (s, 1H), 7.62 (br s, 1H), 7.39 (d, J 
= 8.5 Hz, 1H), 7.18 (br s, 1H), 5.84 (br s, 1H), 5.70 (m, 
1H), 5.01 (m, 2H), 3.96 (s, 3H), 3.37 (br s, 1H), 3.30 
(br s, 1H), 3.18 (m, 1H), 2.79 (br s, 2H), 2.35 (br s, 
1H), 1.72 (s, 1H), 1.68 (m, 2H), 1.41 (m, 1H), 0.92 (br 
s, 1H).  
13
C NMR (CDCl3) δ 181.0, 158.2, 147.4, 
144.8, 144.0, 140.6, 140.0, 132.6 (q, J = 33.6 Hz), 
131.8, 127.9, 123.6, 122.9 (q, J = 273.0 Hz), 122.0, 
118.8, 115.1, 102.1, 61.2, 55.7, 54.9, 41.3, 39.0, 27.5, 
27.1, 25.7.  Mp. 121.0–121.5 °C.  IR (neat): 3220, 
2946, 2360, 1623, 1510, 1475, 1384, 1279, 1180, 
1134, 1032, 959, 917, 885, 850, 683 cm
–1
.  HRMS 
Calcd for C29H29F6N4OS: [M+H]
+
, 595.1966. Found: 
m/z 595.1961. 
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3d. White solid; 44% yield (1.2 g) (for 2steps from 
cinchonidine).  [α]D
23
 –101.0 (c 1.24, CH2Cl2).  
1
H 
NMR (CDCl3) δ 8.80 (br s, 1H), 8.35 (br s, 1H), 8.14 
(d, J = 8.5 Hz, 1H), 7.80 (s, 2H), 7.74 (dd, J = 8.0, 7.5 
Hz, 1H), 7.69 (s, 1H), 7.63 (dd, J = 8.0, 7.5 Hz, 1H), 
7.27 (br s, 1H), 5.78 (br s, 1H), 5.67 (m, 1H), 4.98 (m, 
2H), 3.26 (m, 1H), 3.20 (br s, 1H), 3.17 (dd, J = 13.5, 
10.5 Hz, 1H), 2.78 (m, 2H), 2.33 (br s, 1H), 1.70 (m, 
2H), 1.63 (m, 1H), 1.33 (m, 1H), 0.93 (br s, 1H).  
13
C 
NMR (CDCl3) δ 180.9, 149.9, 148.5, 145.9, 140.7, 
139.9, 132.6 (q, J = 33.6 Hz), 130.4, 129.5, 127.0, 
123.6, 122.9 (q, J = 273.0 Hz), 119.1, 118.9, 115.0, 
61.5, 56.5, 54.9, 41.1, 39.2, 27.5, 27.1, 25.7.  Mp. 
122.8–123.1 °C.  IR (neat): 3240, 3081, 2946, 2366, 
1510, 1473, 1384, 1281, 1181, 1135, 990, 958, 884, 
849, 755, 683 cm
–1
.  HRMS Calcd for C28H27F6N4S: 
[M+H]
+
, 565.1861. Found: m/z 565.1855. 
 
General procedure for asymmetric synthesis of 2-
substituted tetrahydrofurans 2 
In a 5-mL vial, we sequentially added ε-hydroxy-α,β-
unsaturated ketone 1 (0.25 mmol), cyclopentyl methyl 
ether (CPME, 0.5 mL), and quinidine-derived 
bifunctional catalyst 3a (0.0075 mmol).  The mixture 
was stirred in an oil bath maintained at 25 °C for 24 h.  
The reaction mixture was subsequently diluted with 
hexane/EtOAc (v/v = 1/1), passed through a short 
silica gel pad to remove 3a, and concentrated in vacuo.  
Purification of the reaction mixture by flash silica gel 
column chromatography using hexane/EtOAc (v/v = 




General procedure for asymmetric synthesis of 2-
substituted tetrahydropyrans 5 
In a 5-mL vial, we sequentially added ζ-hydroxy-α,β-
unsaturated ketone 4 (0.15 mmol), cyclopentyl methyl 
ether (CPME, 0.3 mL), and quinidine-derived 
bifunctional catalyst 3a (0.0075 mmol).  The mixture 
was stirred in an oil bath maintained at 25 °C for 24 h.  
The reaction mixture was subsequently diluted with 
hexane/EtOAc (v/v = 1/1), passed through a short 
silica gel pad to remove 3a, and concentrated in vacuo.  
Purification of the reaction mixture by flash silica gel 
column chromatography using hexane/EtOAc (v/v = 





Yield: 90% (27.1 mg), 91% ee, colorless oil.  [α]D
26
 
+16.8 (c 2.53, CH2Cl2).  
1
H NMR (CDCl3) δ 7.97 (m, 
2H), 7.56 (m, 1H), 7.46 (m, 2H), 3.96 (m, 2H), 3.48 
(m, 1H), 3.29 (dd, J = 16.0, 6.5 Hz, 1H), 2.92 (dd, J = 
16.0, 5.5 Hz, 1H), 1.84 (m, 1H), 1.75 (m, 1H), 1.57 
(m, 2H), 1.52 (m, 1H), 1.36 (m, 1H).  
13
C NMR 
(CDCl3) δ 198.4, 137.4, 133.0, 128.5, 128.3, 74.4, 
68.7, 45.4, 32.0, 25.9, 23.4.  TLC: Rf 0.45 
(hexane/EtOAc = 3:1).  IR (neat): 3060, 2936, 2849, 
1686, 1597, 1581, 1449, 1379, 1357, 1325, 1292, 
1273, 1208, 1194, 1175, 1088, 1045, 1003, 971, 904, 
810, 777, 751, 692, 661, 471 cm
–1
.  HRMS Calcd for 
C13H17O2: [M+H]
+
, 205.1229. Found: m/z 205.1227.  
HPLC (Daicel Chiralcel OD-H, hexane/i-PrOH = 99/1, 
flow rate = 2.0 mL/min, λ = 254 nm, 40 °C): tminor = 




Yield: 56% (19.7 mg), 94% ee, colorless oil.  [α]D
25
 
+20.8 (c 1.97, CH2Cl2).  
1
H NMR (CDCl3) δ 7.95 (m, 
2H), 6.91 (m, 2H), 3.95 (m, 1H), 3.93 (m, 1H), 3.86 (s, 
3H), 3.47 (m, 1H), 3.23 (dd, J = 16.0, 7.0 Hz, 1H), 
2.86 (dd, J = 16.0, 6.0 Hz, 1H), 1.83 (m, 1H), 1.73 (m, 
1H), 1.59–1.49 (m, 3H), 1.34 (m, 1H).  
13
C NMR 
(CDCl3) δ 196.9, 163.4, 130.5, 130.1, 113.6, 74.4, 
68.6, 55.4, 45.0, 32.0, 25.8, 23.3.  TLC: Rf 0.29 
(hexane/EtOAc = 3:1).  IR (neat): 2934, 2844, 1672, 
1600, 1577, 1510, 1309, 1261, 1170, 1087, 1045, 
1031, 843, 450 cm
–1
.  HRMS Calcd for C14H19O3: 
[M+H]
+
, 235.1329. Found: m/z 235.1377.  HPLC 
(Daicel Chiralpak AD-H, hexane/i-PrOH = 98/2, flow 
rate = 0.5 mL/min, λ = 254 nm, 40 °C): tminor = 34.6 




Reaction wasrun on 0.1 mmolscale. 
Yield: 95% (25.9 mg), 85% ee, white solid.  [α]D
25
 
+3.86 (c 2.59, CH2Cl2).  
1
H NMR (CDCl3) δ 8.06 (m, 
2H), 7.72 (m, 2H), 3.95 (m, 1H), 3.93 (m, 1H), 3.50 
(m, 1H), 3.30 (dd, J = 16.0, 7.0 Hz, 1H), 2.90 (dd, J = 
16.0, 5.0 Hz, 1H), 1.85 (m, 1H), 1.73 (m, 1H), 1.59 
(m, 1H), 1.55 (m, 1H), 1.52 (m, 1H), 1.39 (m, 1H).  
13
C NMR (CDCl3) δ 197.6, 139.9, 134.2 (q, J = 32.7 
Hz), 128.6, 125.6 (q, J = 3.9), 123.5 (q, J = 272.6 Hz), 
74.2, 68.6, 45.6, 31.9, 25.7, 23.3.  
19
F NMR (CDCl3) δ 
98.7.  Mp. 51.5–52.5 °C.  TLC: Rf 0.49 
(hexane/EtOAc = 3:1).  IR (KBr): 2946, 2936, 2925, 
2857, 1681, 1412, 1334, 1323, 1213, 1170, 1158, 1134, 
1124, 1113, 1107, 1084, 1070, 1006, 848, 829 cm
–1
.  
HRMS Calcd for C14H16F3O2: [M+H]
+
, 273.1097. 
Found: m/z 273.1106.  HPLC (Daicel Chiralpak AD-H, 
hexane/i-PrOH = 98/2, flow rate = 0.5 mL/min, λ = 




Yield: 80% (30.5 mg), 94% ee, colorless oil.  [α]D
25
 
+26.7 (c 3.05, CH2Cl2).  
1
H NMR (CDCl3) δ 8.49 (m, 
1H), 8.04 (m, 1H), 7.96 (d, J = 8.5 Hz, 1H), 7.88 (m, 
2H), 7.58 (m, 1H), 7.55 (m, 1H), 4.02 (m, 1H), 3.96 
(m, 1H), 3.51 (m, 1H), 3.45 (dd, J = 16.0, 6.5 Hz, 1H), 
3.05 (dd, J = 16.0, 5.5 Hz, 1H), 1.86 (m, 1H), 1.78 (m, 
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1H), 1.62–1.55 (m, 2H), 1.51 (m, 1H), 1.41 (m, 1H).  
13
C NMR (CDCl3) δ 198.3, 135.5, 134.5, 132.4, 130.1, 
129.6, 128.43, 128.36, 127.7, 126.7, 123.9, 74.4, 68.6, 
45.4, 32.0, 25.8, 23.4.  TLC: Rf 0.36 (hexane/EtOAc = 
3:1).  IR (neat): 3508, 2935, 2848, 2739, 2667, 2314, 
1680, 1636, 1469, 1387, 1355, 1295, 1209, 1087, 863, 
821, 747, 677, 450 cm
–1
.  HRMS Calcd for C17H19O2: 
[M+H]
+
, 255.1380. Found: m/z 255.1388.  HPLC 
(Daicel Chiralpak AD-H, hexane/i-PrOH = 98.5/1.5, 
flow rate = 2.0 mL/min, λ = 254 nm, 40 °C): tminor = 




Yield: 76% (24.9 mg), 94% ee, colorless oil.  [α]D
25
 
+14.9 (c 2.49, CH2Cl2).  
1
H NMR (CDCl3) δ 7.86 (m, 
2H), 7.26 (m, 2H), 3.95 (m, 1H), 3.93 (m, 1H), 3.47 
(m, 1H), 3.23 (dd, J = 16.0, 6.0 Hz, 1H), 2.90 (dd, J = 
16.0, 6.0 Hz, 1H), 2.40 (s, 3H), 1.83 (m, 1H), 1.74 (m, 
1H), 1.58 (m, 1H), 1.54 (m, 1H), 1.49 (m, 1H), 1.35 
(m, 1H).  
13
C NMR (CDCl3) 198.0, 143.8, 134.7, 
129.2, 128.4, 74.4, 68.6, 45.2, 32.0, 25.8, 23.4, 21.6.  
TLC: Rf 0.44 (hexane/EtOAc = 3:1).  IR (neat): 2933, 
2853, 2360, 2331, 1686, 1607, 1087, 1045, 971, 475, 
448 cm
–1
.  HRMS Calcd for C14H19O2: [M+H]
+
, 
219.1380. Found: m/z 219.1389.  HPLC (Daicel 
Chiralpak AD-H, hexane/i-PrOH = 98.5/1.5, flow rate 
= 0.5 mL/min, λ = 254 nm, 40 °C): tminor = 24.0 min, 




Yield: 99% (42.1 mg), 94% ee, white solid.  [α]D
25
 
+10.9 (c 4.21, CH2Cl2).  
1
H NMR (CDCl3) δ 7.81 (m, 
2H), 7.56 (m, 2H), 3.92 (m, 1H), 3.90 (m, 1H), 3.41 
(m, 1H), 3.22 (dd, J = 16.0, 7.0 Hz, 1H), 2.83 (dd, J = 
16.0, 5.5 Hz, 1H), 1.79 (m, 1H), 1.70 (m, 1H), 1.59–
1.52 (m, 2H), 1.48 (m, 1H), 1.35 (m, 1H).  
13
C NMR 
(CDCl3) δ 197.4, 135.8, 131.7, 129.7, 128.2, 74.2, 
68.5, 45.2, 31.9, 25.7, 23.3.  Mp. 55.3–55.5 °C.  TLC: 
Rf 0.49 (hexane/EtOAc = 3:1).  IR (KBr): 2960, 2937, 
2924, 2845, 1684, 1584, 1400, 1207, 1087, 1072, 999, 
973, 835, 807 cm
–1
.  HRMS Calcd for C13H16BrO2: 
[M+H]
+
, 283.0328. Found: m/z 283.0339.  HPLC 
(Daicel Chiralpak AD-H, hexane/i-PrOH = 98/2, flow 
rate = 2.0 mL/min, λ = 254 nm, 40 °C): tminor = 21.7 




Yield: 58% (20.0 mg), 95% ee, colorless oil.  [α]D
25
 
+3.50 (c 2.00, CH2Cl2).  
1
H NMR (CDCl3) δ 7.27 (m, 
2H), 7.20–7.17 (m, 3H), 3.92 (m, 1H), 3.75 (m, 1H), 
3.42 (m, 1H), 2.89 (m, 2H), 2.79 (m, 2H), 2.65 (dd, J 
= 15.5, 6.0 Hz, 1H), 2.38 (dd, J = 15.5, 4.5 Hz, 1H), 
1.81 (m, 1H), 1.58 (m, 1H), 1.53–1.46 (m, 3H), 1.25 
(m, 1H).  
13
C NMR (CDCl3) δ 208.5, 141.1, 130.4, 
128.3, 126.0, 74.1, 68.5, 49.6, 45.2, 31.7, 29.4, 25.7, 
23.3.  TLC: Rf 0.38 (hexane/EtOAc = 3:1).  IR (neat): 
2935, 2854, 1718, 1684, 1653, 1636, 1559, 1539, 
1457, 1088, 1044, 747, 699, 456 cm
–1
.  HRMS Calcd 
for C15H21O2: [M+H]
+
, 233.1536. Found: m/z 
233.1545.  HPLC (Daicel Chiralpak AD-H, hexane/i-
PrOH = 98.5/1.5, flow rate = 0.5 mL/min, λ = 254 nm, 
40 °C): tminor = 14.5 min, tmajor = 15.6 min. 
 
General procedure for asymmetric synthesis of 1,3-
dioxolanes 10 
In a 5-mL vial, we sequentially added γ-hydroxy-α,β-
unsaturated ketone 8 (0.25 mmol), cyclopentyl methyl 
ether (CPME, 0.5 mL), aldehyde or ketone 9 (0.3 
mmol), and quinidine-derived bifunctional catalyst 3a 
(0.025 mmol).  The mixture was stirred in an oil bath 
maintained at 25 °C for 24 h.  The reaction mixture 
was sequentially diluted with hexane/EtOAc (v/v = 
1/1), passed through a short silica gel pad to remove 
3a, and concentrated in vacuo.  Purification of the 
reaction mixture by flash silica gel column 
chromatography using hexane/EtOAc (v/v = 10/1) as 
an eluent afforded the corresponding 1,3-dioxolane 3 
as a mixture of the diastereomers.  In most cases, the 
diastereomers were further separated by flash silica 
gel column chromatography (see ref 20 for details). 
 
Pocedure for asymmetric oxy-Michael addition 
reaction to γ-hydroxy-α,β-unsaturated thioester 14 
In a 5-mL vial, we sequentially added γ-hydroxy-α,β-
unsaturated thioester 14 (2.0 mmol), cyclopentyl 
methyl ether (CPME, 2.0 mL), pivalaldehyde (9d, 4.0 
mmol), and quinidine-derived bifunctional catalyst 3a 
(0.26 mmol).  The mixture was stirred in an oil bath 
maintained at 25 °C for 48 h.  The reaction mixture 
was sequentially diluted with hexane/EtOAc (v/v = 
1/1), passed through a short silica gel pad to remove 
3a, and concentrated in vacuo.  Purification of the 
reaction mixture by flash silica gel column 
chromatography using hexane/Et2O (v/v = 10/1) as an 
eluent afforded the corresponding oxy-Michael 
adducts 15 and 15′ as a mixture of the diastereomers. 
 
See ref 14, 20, and 24 for further details on the 
experimental procedures and the characterization data 
of compounds. 
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